Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Bevacizumab|DRUG: Docetaxel
Sponsor: Bhuvaneswari Ramaswamy
Collaborators: Genentech, Inc.|Case Comprehensive Cancer Center|University of Pittsburgh